Timing mistakes Taking AOD-9604 with food, particularly carbohydrate-containing meals, substantially reduces effectiveness
Other At-Risk Groups GLP-1 medications are generally not suitable for individuals with severe gastrointestinal disorders like gastroparesis, those with type 1 diabetes (as these drugs are approved only for type 2 diabetes and obesity), and people with a history of suicidal thoughts, active eating disorders, or heavy alcohol use
Irritation or adverse reactions Skin irritation from topical application usually responds to reducing frequency or concentration
It should not make the hallway feel like a moving sidewalk
Explore how peptides work, how theyre delivered through our InstaRelease strips, and which product may be right for you
Is CagriSema just semaglutide with cagrilintide added